Drugs / Local Standard-Dose Inactivated Quadrivalent Influenza Vaccine
Local Standard-Dose Inactivated Quadrivalent Influenza Vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04498832 Comparator | Oct 2020 → Jan 2021 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Local Standard-Dose Inactivated Quadrivalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04498832 ↗ |
| Modality | Vaccine | “standard-dose quadrivalent influenza vaccine” NCT04498832 ↗ |
| Route | Subcutaneous | “Route of administration: SC” NCT04498832 ↗ |